Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study.
Strahlenther Onkol
; 199(5): 456-464, 2023 05.
Article
in En
| MEDLINE
| ID: mdl-36450836
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Radiosurgery
/
Kidney Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Strahlenther Onkol
Year:
2023
Document type:
Article